RestorixHealth Acquires CūtisCare to Enhance Wound Management Solutions through Strategic Partnership

RestorixHealth Strengthens Wound Care Leadership with CūtisCare Acquisition

Published: October 29, 2025

RestorixHealth has expanded its reach in specialized wound care services through the acquisition of CūtisCare, a provider of hyperbaric medicine and hospital-based care. This strategic move positions RestorixHealth as a dominant force in the increasingly vital field of advanced wound healing.

Expanding Capabilities with Hyperbaric Expertise

The acquisition brings together CūtisCare’s specialization in hyperbaric oxygen therapy with RestorixHealth’s established operational and clinical framework. This synergy is designed to enhance the delivery of care and broaden the range of services offered to hospital partners nationwide. Hyperbaric oxygen therapy, which involves breathing pure oxygen in a pressurized environment, is known to accelerate healing, especially for chronic wounds.

According to a 2024 report by the University of Pittsburgh Medical Center, hyperbaric oxygen therapy shows promising results in treating diabetic foot ulcers and radiation-induced injuries – conditions where traditional methods often fall short. The combination of CūtisCare’s expertise and RestorixHealth’s infrastructure promises to bring thes advanced treatments to more patients.

Strategic Alignment and Growth Potential

RestorixHealth CEO Ben Dunford highlighted that the integration of these two entities creates a comprehensive solution for healthcare facilities of all sizes. “Integrating CūtisCare and RestorixHealth’s hospital-based services positions us as the leading solution for partners of all sizes across all communities,” Dunford stated. The company is focused on accelerating growth and expanding access to advanced wound care for patients needing specialized treatment.

The acquisition does not include CūtisCare’s RegenQuest division, which will continue to operate independently, focusing on office-based wound care and hyperbaric programs.

Commitment to Clinical Excellence and Research

RestorixHealth’s chief medical officer, Dr. William Tettelbach, emphasized the enhanced clinical leadership the acquisition provides. “This arrangement brings unmatched leadership and clinical expertise, empowering our healthcare partners and frontline providers to deliver safer, more effective, evidence-based patient care,” Dr. Tettelbach explained. Collaboration with research institutions will be crucial for ongoing investment in proven clinical protocols.

did you Know? Chronic wounds affect approximately 6.5 million Americans and cost the healthcare system an estimated $97 billion annually, according to the American Podiatric Medical Association.

Expanded National Footprint

Through this strategic alliance with academic medical centers, hospitals, and healthcare systems like UC San Diego Health, UCLA Medical center, and Yale New Haven Health, RestorixHealth now serves approximately 300 partners across 41 states. This extensive network allows for broader reach and increased access to specialized wound care solutions.

Partner Hospital System	State
UC san Diego Health	California
UCLA Medical center	California
Yale New Haven Health	Connecticut

Recent Strategic Partnerships

This acquisition follows a strategic arrangement announced in April 2024 between RestorixHealth and Accurate Healthcare, aimed at creating a dedicated service provider for the skilled nursing industry. These moves demonstrate RestorixHealth’s commitment to expanding its presence across the continuum of care.

The Growing Importance of Advanced Wound Care

The demand for advanced wound care services is steadily increasing, driven by factors such as an aging population, the rising prevalence of diabetes, and advancements in medical treatments that extend lifespans. Chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, pose significant challenges to both patients and healthcare providers.

Pro Tip: Early intervention and specialized treatment are crucial for preventing chronic wounds from escalating and leading to complications like amputation.

Frequently Asked Questions about RestorixHealth and CūtisCare

• what services does CūtisCare provide? CūtisCare specializes in multi-place hyperbaric medicine and hospital-based services.
• What is hyperbaric oxygen therapy? It’s a treatment involving breathing pure oxygen in a pressurized environment to accelerate healing, particularly for arduous-to-heal wounds.
• What is RestorixHealth’s role after the acquisition? RestorixHealth will integrate CūtisCare’s services with its existing operational,clinical,and financial expertise.
• Will RegenQuest continue to operate? Yes, CūtisCare’s RegenQuest division will remain a separate entity focused on office-based wound healing.
• How many partners does restorixhealth now have? RestorixHealth now serves around 300 partners in 41 states.
• What is the potential benefit to patients? Expanded access to advanced wound care treatments and improved healing outcomes.

What are yoru thoughts on the increasing consolidation in the wound care industry? Share your comments below!

How does the combined expertise of RestorixHealth and CūtisCare address gaps in access to advanced wound care for patients with limited mobility?

RestorixHealth Acquires CūtisCare: A New Era in Wound Management

Expanding Capabilities in Chronic Wound Care

RestorixHealth’s recent acquisition of CūtisCare marks a significant development in the landscape of advanced wound care. This strategic partnership combines the strengths of two leading providers, promising enhanced solutions for patients suffering from chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure injuries. The move is poised to reshape how wound healing is approached, particularly within the outpatient wound care setting.

Synergies Between RestorixHealth and CūtisCare

Both RestorixHealth and CūtisCare have established reputations for delivering high-quality wound care services.Though, their areas of expertise complement each other, creating a powerful synergy.

* RestorixHealth: Known for its network of hospital-based wound care centers and extensive hyperbaric oxygen therapy (HBOT) programs. They specialize in complex wound cases requiring advanced interventions.

* CūtisCare: A leading provider of mobile wound care services, bringing specialized treatment directly to patients in skilled nursing facilities, assisted living communities, and patients’ homes. This expands access to care for those with limited mobility or transportation options.

This acquisition allows RestorixHealth to extend its reach beyond traditional hospital settings, offering a more convenient and accessible model of wound treatment. CūtisCare benefits from RestorixHealth’s resources and expertise in advanced therapies like HBOT.

The Impact on Patients: Improved Access and Outcomes

The primary beneficiary of this partnership is the patient. Here’s how the acquisition is expected to improve wound care outcomes:

1. Increased Access to Specialized Care: Mobile wound care services eliminate barriers to treatment for patients who cannot easily travel to a wound care center.
2. continuum of Care: Seamless transition between hospital-based and mobile services ensures consistent, coordinated care throughout the healing process.
3. Advanced Therapies: Patients gain access to a wider range of wound healing technologies and treatments, including HBOT, negative pressure wound therapy (NPWT), and advanced wound dressings.
4. Reduced Healthcare costs: Proactive wound prevention and early intervention through mobile services can prevent wound deterioration, reducing the need for costly hospitalizations and surgeries.

Key Technologies and Treatment Modalities

The combined entity will offer a comprehensive suite of wound management solutions, including:

* Hyperbaric Oxygen Therapy (HBOT): Utilizing pressurized oxygen to stimulate tissue repair and fight infection. Particularly effective for diabetic foot ulcers and radiation-injured tissues.

* Negative Pressure Wound Therapy (NPWT): Applying controlled suction to promote granulation tissue formation and reduce edema.

* Advanced Wound Dressings: Utilizing innovative materials like collagen,alginates,and hydrogels to create an optimal wound healing surroundings.

* Debridement: Removing dead or infected tissue to promote healing. Both surgical and enzymatic debridement techniques will be available.

* Diabetic Foot Care: Specialized care for patients with diabetic ulcers, including offloading, education, and preventative measures.

* Lymphedema Management: Addressing swelling and tissue damage associated with lymphedema, which can contribute to chronic wounds.

Benefits for Healthcare Providers and Facilities

The RestorixHealth-CūtisCare partnership also offers significant benefits for healthcare providers and facilities:

* Enhanced Wound Care Programs: Hospitals and skilled nursing facilities can outsource their wound care needs to a specialized provider, improving quality of care and reducing liability.

* Revenue Generation: Mobile wound care services can generate new revenue streams for facilities.

* Reduced Hospital Readmissions: Effective wound care reduces the risk of wound-related complications and hospital readmissions.

* Improved Patient Satisfaction: Convenient access to specialized care and improved outcomes lead to higher patient satisfaction scores.

The Future of Wound Care: A Proactive Approach

This acquisition signals a shift towards a more proactive and patient-centered approach to wound care. By bringing specialized services directly to patients and leveraging advanced technologies, RestorixHealth and CūtisCare are poised to lead the way in improving wound healing rates and enhancing the quality of life for individuals suffering from chronic wounds. The focus will increasingly be on wound prevention strategies alongside advanced treatment options.